Suche nachNadine P. Flynn

Region
Status
Waren und Dienstleistungen

Ihre Suche hat mehr als 1000 Treffer ergeben. Bitte filtern Sie die Ergebnisse, um die Anzahl der Treffer zu reduzieren.

Land
Aktenzeichen
Marke
Klasse(n)
Inhaber
Anmeldung
Eintragung
Schutzende
Status
USPTO
78589291
ERLATECT
910
Bristol-Myers Squibb Company
17.03.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78589289
DETECTIL
910
Bristol-Myers Squibb Company
17.03.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78589288
DETECOR
910
Bristol-Myers Squibb Company
17.03.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78589286
DETECRO
910
Bristol-Myers Squibb Company
17.03.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78589280
DETECRA
910
Bristol-Myers Squibb Company
17.03.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78589278
ATTECTION
910
Bristol-Myers Squibb Company
17.03.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78589276
ARROCOR
910
Bristol-Myers Squibb Company
17.03.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78583406
INSURGE
5
Bristol-Myers Squibb Company
09.03.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78573170
BECAUSE YOU CONSIDER THE WHOLE PATIENT
16
Bristol-Myers Squibb Company
23.02.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78567671
TUBLINOR
5
Bristol-Myers Squibb Company
15.02.2005
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Darum lohnt sich ein kostenfreier TMDB Account

Marken überwachen und schützen

Wenn Sie eine Markenüberwachung eingerichtet haben, erhalten Sie automatisch eine E-Mail über Nachahmer und Trittbrettfahrer. So funktioniert unkomplizierter Markenschutz in Echtzeit.

Marken ganz einfach folgen

Wenn Sie einer Marke folgen, erhalten Sie eine E-Mail bei neuen Anmeldungen, Widersprüchen, Fristen und Verlängerungen u.v.m. – So bleiben Sie auf dem Laufenden was die Entwicklung einer Marke angeht.

Kostenfrei registrieren
USPTO
78567669
LONVIVET
5
Bristol-Myers Squibb Company
15.02.2005
-
-
ABANDONED - EXPRESS
USPTO
78567666
VORZEPA
5
Bristol-Myers Squibb Company
15.02.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78557879
TYNAGO
5
Bristol-Myers Squibb Company
01.02.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78556725
INNOVATION FOR THE NEXT FUTURE
16
Bristol-Myers Squibb Company
31.01.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78556723
DISCOVERING THE NEXT FUTURE
16
Bristol-Myers Squibb Company
31.01.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78555592
WITH RESEARCH COMES UNDERSTANDING, WITH UNDERSTANDING COMES POSSIBILITIES
542
Bristol-Myers Squibb Company
28.01.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78555578
STEXMEDOR
5
Bristol-Myers Squibb Company
28.01.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78555576
ORSPECTA
5
Bristol-Myers Squib Company
28.01.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78554721
5
Bristol-Myers Squibb Company
27.01.2005
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78551539
DRESARC
5
Bristol-Myers Squibb Company
21.01.2005
-
-
ABANDONED - AFTER PUBLICATION
USPTO
78538550
BEPRESALTAN
5
Bristol-Myers Squibb Company
27.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78538547
BENTECADUSE
5
Bristol-Myers Squibb Company
27.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78536836
BEVERADUSE
5
Bristol-Myers Squibb Company
22.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78536834
BESPRESSA
5
Bristol-Myers Squibb Company
22.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78536832
BENTADUSE
5
Bristol-Myers Squibb Company
22.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78536829
BENTADUCE
5
Bristol-Myers Squibb Company
22.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78536742
FIRST SWITCH
5
Mead Johnson & Company
22.12.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78535370
EXTENDING AND ENHANCHING HUMAN LIFE
1642
Bristol-Myers Squibb Company
20.12.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78534311
BARADUSE
5
Bristol-Myers Squibb Company
17.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78534207
STAXMEDOR
5
Bristol-Myers Squibb Company
17.12.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78534205
ORSPECTO
5
Bristol-Myers Squibb Company
17.12.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78534204
ZEKMEDOR
5
Bristol-Myers Squibb Company
17.12.2004
-
-
ABANDONED - AFTER PUBLICATION
USPTO
78534203
MULDORZA
5
Bristol-Myers Squibb Company
17.12.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78531431
ORZULTI
5
Bristol-Myers Squibb Company
13.12.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78531426
ORZONTA
5
Bristol-Myers Squibb Company
13.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78531208
STEZANAX
5
Bristol-Myers Squibb Company
13.12.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78523762
HEPB HOPE WE WANT TO MAKE HOPE AS INFECTIOUS AS HEPATITIS B
16
Bristol-Myers Squibb Company
29.11.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
78521506
ORZINDO
5
Bristol-Myers Squibb Company
23.11.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78521505
ONSOMBLA
5
Bristol-Myers Squibb Company
23.11.2004
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
78519036
FREVELAS
510
Bristol-Myers Squibb Company
18.11.2004
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Suchergebnisse 801 - 841 von 1000+

Wir lieben Marken.
Und betreuen Sie gerne.

Sie erreichen uns von Montag bis Freitag zwischen 08:00–16:00 Uhr.

Kontaktieren Sie uns.

Wir verwenden Cookies, um Ihre Einstellungen und Statistiken zu speichern und unseren Inhalt zu verbessern. Durch Klicken auf "Alle akzeptieren" akzeptieren Sie die Verwendung von Cookies.

Akzeptieren